Page 1 of Clinical Trials for open-label, 55719 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
Last Updated: January 22, 2011
Condition(s): Hypertriglyceridemia
2
Withdrawn
International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia
Last Updated: November 19, 2010
Condition(s): Hypervolemic Hyponatremia
3
Completed
An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease
Last Updated: August 30, 2011
Condition(s): Idiopathic Parkinson's Disease
4
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
Last Updated: August 30, 2011
Condition(s): Early Stage Parkinson's Disease
5
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease
Last Updated: August 30, 2011
Condition(s): Parkinson's Disease
6
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.
Last Updated: August 30, 2011
Condition(s): Early-Stage Parkinson's Disease
7
Completed
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease
Last Updated: March 28, 2012
Condition(s): Advanced Stage Parkinson's Disease
8
Completed
Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)
Last Updated: October 14, 2011
Condition(s): Restless Legs Syndrome
9
Completed
Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects
Last Updated: September 3, 2010
Condition(s): Hypertriglyceridemia
10
Completed
Pilot Study of Open-label Placebo to Treat Major Depressive Disorder
Last Updated: July 20, 2011
Condition(s): Major Depressive Disorder
11
Not yet recruiting
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Last Updated: March 20, 2012
Condition(s): Pulmonary Arterial Hypertension
12
Active, not recruiting
Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer
Last Updated: March 15, 2012
Condition(s): Prostate Cancer
13
Recruiting
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Last Updated: May 10, 2012
Condition(s): Infection, Human Immunodeficiency Virus
14
Completed
An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
Last Updated: October 15, 2008
Condition(s): Bipolar Disorder
15
Completed
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
Last Updated: April 20, 2012
Condition(s): Eosinophilic Esophagitis
16
Terminated
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Last Updated: April 12, 2012
Condition(s): Alzheimer's Disease; Mild-to-moderate Alzheimers Disease
17
Active, not recruiting
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
Last Updated: October 21, 2009
Condition(s): Dyslipidemia
18
Completed
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
Last Updated: January 18, 2012
Condition(s): Mixed Dyslipidemia
19
Terminated
Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
Last Updated: August 1, 2008
Condition(s): Alzheimer's Disease
20
Completed
Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects
Last Updated: April 29, 2009
Condition(s): Renal Insufficiency, Chronic; Hepatic Insufficiency; Healthy

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=open-label

Page 1 of Clinical Trials for open-label, 55719 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About